Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Macrocyclic Peptide
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : BridgeBio Pharma
Deal Size : Undisclosed
Deal Type : Agreement
Unnatural & BridgeBio Partner on Macrocyclic Therapeutics for Rare Diseases
Details : Under the terms of the agreement, UNP assumed responsibility for R&D, and BridgeBio will assume the further development of the macrocyclic peptide candidates for rare diseases and oncology.
Brand Name : Undisclosed
Molecule Type : Peptide
Upfront Cash : Undisclosed
December 03, 2024
Lead Product(s) : Macrocyclic Peptide
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : BridgeBio Pharma
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?